Publikationen in Zusammenarbeit mit Forschern von Pharmacoeconomics and Outcomes Research Iberia (3)

2023

  1. Recommendations to standardize patients' follow-up after interventional procedures in chronic pain treatment: A Delphi study

    Pain Practice, Vol. 23, Núm. 6, pp. 618-625

2012

  1. Cost-effectiveness analysis of disease modifiying drugs (interferons and glatiramer acetate) as first line treatments in remitting-relapsing multiple sclerosis patients

    Journal of Medical Economics, Vol. 15, Núm. 3, pp. 424-433

2010

  1. Cost-effectiveness analyses of docetaxel versus paclitaxel once weekly in patients with metastatic breast cancer in progression following anthracycline chemotherapy, in Spain

    Clinical and Translational Oncology, Vol. 12, Núm. 10, pp. 692-700